Search

Author/Creator Jaslowski, Anthony

1. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134. Issue 2 (27th September 2022)

Authors:
Atkins, Michael B.; Lee, Sandra J.; Chmielowski, Bartosz; Tarhini, Ahmad A.; Cohen, Gary I.; Truong, Thach-Giao; Moon, Helen H.; Davar, Diwakar; O'Rourke, Mark; Stephenson, Joseph J.; Curti, Brendan D.; Urba, Walter J.; Brell, Joanna M.; Funchain, Pauline; Kendra, Kari L.; Ikeguchi, Alexandra P.;...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Issue 4 (April 2017)

Authors:
Smith, Sonali M; Pitcher, Brandelyn N; Jung, Sin-Ho; Bartlett, Nancy L; Wagner-Johnston, Nina; Park, Steven I; Richards, Kristy L; Cashen, Amanda F; Jaslowski, Anthony; Smith, Scott E; Cheson, Bruce D; Hsi, Eric; Leonard, John P
Journal:
Lancet
Issue:
Volume 4:Issue 4(2017)
Page Start:
e176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search